MS patients
field of MS therapy
antigen-specific cell therapy
innovative cell therapy approach
ANTIGEN-SPECIFIC TOLERIZATION
inflammatory neurodegenerative disease
specific tolerance
INFLAMMATION
BALANCE
inflammatory assaults
untreatable disease
clinical practicality
clinical outcome
single-center clinical trials
REGENERATION Multiple sclerosis
chronic inflammatory processes
remaining capacity of neuronal self-renewal
principle of therapeutic efficacy of antigen
future efforts
patient monitoring
lives of patients
promising approach
leading cause of non-traumatic disabling neurological disease
centralized MRI monitoring
radiological correlates of neurodegeneration
young adults
different EU countries
consented biobanking
data safeguarding
accessibility
dendritic cells
potential
central nervous system
collaborative network of European centers
protective immunity
GER
NL
cancer
tolDC
advancement
COST Action BM1305
cure
multidisciplinary team
set-up
proof
pathogens
damaging immune reactions
people
results
immunomonitoring
safety
additional partners
level of testing
regulatory approvals
place
focuses
repair
objectives
context
breakthrough
healthcare